Transgender boys sue University of Missouri for denying puberty blockers and hormones

The lawsuit alleges that halting prescriptions for transgender minors unconstitutionally discriminates on the basis of sex and disability status. Mu Health's decision was based on a new Missouri law restricting gender-affirming care, even though the law allows people already receiving treatment to continue.
Two transgender boys filed a federal lawsuit Thursday seeking to reverse the University of Missouri’s decision to stop providing gender-affirming care to minors.

The lawsuit, filed in the U.S. District Court for the Western District of Missouri, alleges halting transgender minors’ prescriptions unconstitutionally discriminates on the basis of sex and disability status.

University of Missouri Health announced Aug. 28 that it would no longer provide puberty blockers and hormones to minors for the purpose of gender transition.

The decision was based on a new lawbanning transgender minors from beginning gender-affirming care. It included a provision to allow people those already receiving treatment to continue, but some providers stopped completely because of a clause included in the new law that they feared opened them to legal liability.

Washington University joined MU Health in dropping its gender-affirming care for minors.